COMPANY LETTERHEAD]Registration Rights Agreement • April 9th, 2024 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 9th, 2024 Company Industry JurisdictionSubject to and in consideration of an investment in Acrivon Therapeutics, Inc., a Delaware corporation (the “Company”), by [__] (collectively, the “Investor”), the parties to this letter hereby agree as follows:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 1st, 2021 • Kodiak Sciences Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made as of March 1, 2021 by and among Kodiak Sciences Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Schedule A who are signatories to this Agreement (each, an “Investor,” and collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.